BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22683612)

  • 1. Clinical benefit of response in chronic graft-versus-host disease.
    Inamoto Y; Martin PJ; Chai X; Jagasia M; Palmer J; Pidala J; Cutler C; Pavletic SZ; Arora M; Jacobsohn D; Carpenter PA; Flowers ME; Khera N; Vogelsang GB; Weisdorf D; Storer BE; Lee SJ;
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1517-24. PubMed ID: 22683612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.
    Palmer JM; Lee SJ; Chai X; Storer BE; Flowers ME; Schultz KR; Inamoto Y; Cutler C; Pidala J; Arora M; Jacobsohn DA; Carpenter PA; Pavletic SZ; Martin PJ
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1649-55. PubMed ID: 22691695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
    Merkel EC; Mitchell SA; Lee SJ
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):752-758. PubMed ID: 26751003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.
    Pidala J; Chai X; Martin P; Inamoto Y; Cutler C; Palmer J; Weisdorf D; Pavletic S; Arora M; Jagasia M; Jacobsohn D; Lee SJ
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):967-72. PubMed ID: 23542686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
    Baird K; Steinberg SM; Grkovic L; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Datiles MB; Bishop R; Bassim CW; Mays JW; Edwards D; Cole K; Avila DN; Taylor T; Urban A; Joe GO; Comis LE; Berger A; Stratton P; Zhang D; Shelhamer JH; Gea-Banacloche JC; Sportes C; Fowler DH; Gress RE; Pavletic SZ
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):632-9. PubMed ID: 23340040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.
    Martin PJ; Storer BE; Palmer J; Jagasia MH; Chen GL; Broady R; Arora M; Pidala JA; Hamilton BK; Lee SJ
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1869-1874. PubMed ID: 31085305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.
    Martin PJ; Storer BE; Inamoto Y; Flowers MED; Carpenter PA; Pidala J; Palmer J; Arora M; Jagasia M; Arai S; Cutler CS; Lee SJ
    Blood; 2017 Jul; 130(3):360-367. PubMed ID: 28495794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral manifestations compatible with chronic graft-versus-host disease in patients with Fanconi anemia.
    Grein Cavalcanti L; Fuentes Araújo RL; Bonfim C; Torres-Pereira CC
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):275-80. PubMed ID: 25316110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
    Lee Sk; Cook EF; Soiffer R; Antin JH
    Biol Blood Marrow Transplant; 2002; 8(8):444-52. PubMed ID: 12234170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.
    Pidala J; Kurland BF; Chai X; Vogelsang G; Weisdorf DJ; Pavletic S; Cutler C; Majhail N; Lee SJ
    Haematologica; 2011 Oct; 96(10):1528-35. PubMed ID: 21685473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.
    Vasconcellos de Souza C; Vigorito AC; Miranda ECM; Garcia C; Rensi Colturato VA; Mauad MA; Rodrigues Moreira MC; da Silva Bouzas LF; Lermontov S; Hamerschlak N; Rodrigues M; Carlos de Almeida Barros J; Chiattone R; Lee SJ; Flowers MED
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1313-1318. PubMed ID: 27058616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
    Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
    Lee SJ; Wolff D; Kitko C; Koreth J; Inamoto Y; Jagasia M; Pidala J; Olivieri A; Martin PJ; Przepiorka D; Pusic I; Dignan F; Mitchell SA; Lawitschka A; Jacobsohn D; Hall AM; Flowers ME; Schultz KR; Vogelsang G; Pavletic S
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):984-99. PubMed ID: 25796139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.
    Curtis LM; Datiles MB; Steinberg SM; Mitchell SA; Bishop RJ; Cowen EW; Mays J; McCarty JM; Kuzmina Z; Pirsl F; Fowler DH; Gress RE; Pavletic SZ
    Haematologica; 2015 Sep; 100(9):1228-36. PubMed ID: 26088932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.
    Palmer J; Williams K; Inamoto Y; Chai X; Martin PJ; Tomas LS; Cutler C; Weisdorf D; Kurland BF; Carpenter PA; Pidala J; Pavletic SZ; Wood W; Jacobsohn D; Arai S; Arora M; Jagasia M; Vogelsang GB; Lee SJ
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):337-44. PubMed ID: 24315845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes and health status associated with chronic graft-
    Lee SJ; Onstad L; Chow EJ; Shaw BE; Jim HSL; Syrjala KL; Baker KS; Buckley S; Flowers ME
    Haematologica; 2018 Sep; 103(9):1535-1541. PubMed ID: 29858386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.
    Ponce DM; Gonzales A; Lubin M; Castro-Malaspina H; Giralt S; Goldberg JD; Hanash AM; Jakubowski A; Jenq R; Papadopoulos EB; Perales MA; van den Brink MR; Young JW; Boulad F; O'Reilly RJ; Prockop S; Small TN; Scaradavou A; Kernan NA; Stevens CE; Barker JN
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):904-11. PubMed ID: 23416854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
    Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
    JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.
    Pavletic SZ; Martin P; Lee SJ; Mitchell S; Jacobsohn D; Cowen EW; Turner ML; Akpek G; Gilman A; McDonald G; Schubert M; Berger A; Bross P; Chien JW; Couriel D; Dunn JP; Fall-Dickson J; Farrell A; Flowers ME; Greinix H; Hirschfeld S; Gerber L; Kim S; Knobler R; Lachenbruch PA; Miller FW; Mittleman B; Papadopoulos E; Parsons SK; Przepiorka D; Robinson M; Ward M; Reeve B; Rider LG; Shulman H; Schultz KR; Weisdorf D; Vogelsang GB;
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):252-66. PubMed ID: 16503494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.
    Sun YC; Chai X; Inamoto Y; Pidala J; Martin PJ; Flowers ME; Shen TT; Lee SJ; Jagasia M
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1687-91. PubMed ID: 26033283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.